睡眠ソフトウェア市場 – 2030年までの世界予測

Report Overview

The global Sleep Software market is projected to reach USD 1,569.2 Million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period.

世界の睡眠ソフトウェア市場は、予測期間中に10.1％のCAGRで、2024年の8億7,890万米ドルから2030年までに15億6,920万米ドルに達すると予測されています。

The growth in the sleep software market is driven by the shift towards preventive health since individuals and health systems are putting more emphasis on proactive wellness approaches rather than reacting to treatments. Sleep software can play a major role in such a shift by allowing users to track their sleep, spot early sleep issues, and develop healthier habits for long-term wellness. As awareness grows about the link between sleep quality and chronic conditions such as obesity, heart disease, and mental health disorders, consumers are increasingly adopting tools that help address potential issues before they become serious.

個人や医療システムは治療に反応するよりも予防​​的な健康アプローチに重点を置いているため、睡眠ソフトウェア市場の成長は予防的健康への移行によって推進されています。睡眠ソフトウェアは、ユーザーが自分の睡眠を追跡し、初期の睡眠の問題を発見し、長期的な健康のためのより健康的な習慣を身につけることを可能にすることで、このような変化において重要な役割を果たすことができます。睡眠の質と肥満、心臓病、精神的健康障害などの慢性疾患との関連性についての意識が高まるにつれ、潜在的な問題が深刻になる前に対処できるツールを消費者が導入するケースが増えています。

“The mobile applications segment is expected to register the fastest growth during the forecast period, by offering”

The Sleep Software market, by offering, is segmented into platforms and applications. The mobile applications segment is expected to grow the fastest during the forecast period due to the rapid growth of mobile-based applications in the sleep software market, which is driven by rising awareness of sleep health, increasing sleep disorders, and advancements in technology. Sleep apps such as Sleep Cycle, Calm, and Headspace offer features such as tracking, relaxation, and integration with wearables. Demand is further increased by stressful lives and health trends, with products such as Moshi for kids and CBT-I Coach for sleeplessness. These apps are now widely available and crucial for improved sleep management due to their affordable models and pandemic-driven mental health focus.

“Cloud-based segment dominated the sleep software market, by deployment model.”

By deployment model, the Sleep Software market is divided into on-premise models and cloud-based models. In 2023, cloud-based models, by deployment model, held a large share of the Sleep Software market. Owing to its scalability, cost efficiency, and accessibility. Cloud solutions enable easy expansion without significant infrastructure costs while providing users with real-time data synchronization across devices. The cloud platforms offer robust data security and seamless updates that continue to allow access to the latest feature upgrades. Integration capabilities with other health platforms and global reach provide an added strength in terms of dominance in the market share.

“Asia Pacific is expected to register the fastest market growth during the forecast period.”

The Sleep Software market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The sleep software market in the Asia Pacific region is being driven by growing awareness of sleep’s critical role in health and productivity, with rising consumer focus on addressing issues like insomnia and sleep apnea, exacerbated by urbanization and high-stress lifestyles. The growing middle class and increasing disposable incomes in key markets such as India, China, and Indonesia fuel  demand for innovative sleep solutions, including apps and wearable integrations, as consumers focus on wellness and invest in health-focused technologies.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation – Directors: 30%, Manager: 34%, and Others: 36%
• By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3% and Middle East & Africa: 2%

List of Companies Profiled in the Report

• Koninklijke Philips N.V. (Netherlands)
• Cadwell Industries Inc. (US)
• COMPUMEDICS LIMITED (Australia)
• Neurovirtual. (US)
• NIHON KOHDEN CORPORATION (Japan)
• Nox Medical (Iceland)
• Natus Medical Incorporated (ARCHIMED) (US)
• RXNT (US)
• Resmed (US)
• Cleveland Medical Devices Inc. (US)
• SOMNOmedics AG (Germany)
• CIDELEC (France)
• Calm (US)
• Sleep Cycle (Sweden)
• Headspace Inc. (US)
• Löwenstein Medical SE & Co. KG (Germany)
• CamNtech Ltd (United Kingdom)
• Fisher & Paykel Healthcare Limited. (New Zealand)
• BioSerenity (France)
• VYAIRE MEDICAL INC (US)
• Inspire Medical Systems, Inc. (US)
• HoneyNaps (South Korea)
• Sleep Reset (US)
• SleepImage. (US)
• BigHealth (US)
• Bodymatter, Inc. (US)
• Neybox Digital Ltd. (US)
• Consumer Sleep Solutions LLC. (US)

Research Coverage:

The report analyzes the sleep software market and aims to estimate the market size and future growth potential of various market segments based on type, offering, function, indication, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for stakeholders in the market. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total sleep software market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (growing incidence of sleep disorders, increasing adoption of telehealth and mhealth, increasing emphasis on corporate wellness programs, growing awareness regarding sleep apnea and wellness improvement, favorable reimbursement and financial aid for sleep apnea devices and therapies), restraints (use of alternative therapies and medications for sleep disorders, data security and privacy concerns, resistance from tradition healthcare providers), opportunities (adoption of advanced technologies, integration with wearable devices, personalized sleep solutions, mental health and wellness integration), challenges (lack of clinical validation for many solutions, regulatory compliance complexities, growing concerns about data privacy and security.) are factors contributing the growth of the sleep software market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the sleep software market.
• Market Development: Comprehensive information on the lucrative emerging markets, type, offering, function, indications, deployment model, end user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the sleep software market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global sleep software market such as Koninklijke Philips N.V. (Netherlands), Resmed (US), Calm (US), Headspace Inc. (US), Inspire Medical Systems, Inc. (US).

Table of Contents

1               INTRODUCTION              29

1.1           STUDY OBJECTIVES       29

1.2           MARKET DEFINITION   29

1.3           MARKET SCOPE                30

1.3.1        MARKET SEGMENTATION           30

1.3.2        INCLUSIONS & EXCLUSIONS       31

1.3.3        YEARS CONSIDERED      32

1.3.4        CURRENCY CONSIDERED            32

1.4           MARKET STAKEHOLDERS            33

2               RESEARCH METHODOLOGY       34

2.1           RESEARCH DATA              34

2.1.1        SECONDARY DATA          35

2.1.1.1    Key data from secondary sources       36

2.1.2        PRIMARY DATA 36

2.1.2.1    Key industry insights           38

2.2           MARKET ESTIMATION METHODOLOGY               39

2.3           MARKET SIZE ESTIMATION         39

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 45

2.5           RESEARCH ASSUMPTIONS           46

2.5.1        MARKET SIZING ASSUMPTIONS                46

2.5.2        OVERALL STUDY ASSUMPTIONS              46

2.6           RISK ASSESSMENT           47

2.7           RESEARCH LIMITATIONS             47

2.7.1        METHODOLOGY-RELATED LIMITATIONS           47

2.7.2        SCOPE-RELATED LIMITATIONS                 47

3               EXECUTIVE SUMMARY  48

4               PREMIUM INSIGHTS       54

4.1           SLEEP SOFTWARE MARKET OVERVIEW 54

4.2           NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION                55

4.3           SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX 56

4.4           SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES               56

5               MARKET OVERVIEW       57

5.1           INTRODUCTION              57

5.2           MARKET DYNAMICS       57

5.2.1        DRIVERS               59

5.2.1.1    Expansion of telehealth and remote patient monitoring                 59

5.2.1.2    Vast population of undiagnosed sleep apnea patients    59

5.2.1.3    Growing awareness regarding sleep apnea and wellness improvement         61

5.2.1.4    Favorable reimbursement and financial aid for sleep apnea devices and therapies           62

5.2.1.5    Increasing emphasis on corporate wellness programs    62

5.2.2        RESTRAINTS      63

5.2.2.1    Data privacy and security concerns   63

5.2.2.2    Use of alternative therapies and medications for sleep disorders                 66

5.2.2.3    Resistance from traditional healthcare providers             67

5.2.3        OPPORTUNITIES              68

5.2.3.1    Development of mHealth tools          68

5.2.3.2    Rising potential of AI & ML in sleep medicine                69

5.2.3.3    Rising demand for smart wearables   70

5.2.3.4    Increasing focus on mental health and wellbeing            70

5.2.4        CHALLENGES    71

5.2.4.1    Lack of clinical validation of sleep apps            71

5.2.4.2    Strategic challenges in monetizing sleep apps 71

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       72

5.4           INDUSTRY TRENDS         72

5.4.1        VALUE-BASED CARE MODELS    72

5.4.2        CLOUD-BASED SOLUTIONS        73

5.4.3        IOT AND WEARABLES    73

5.5           ECOSYSTEM ANALYSIS  74

5.6           SUPPLY CHAIN ANALYSIS             77

5.7           TECHNOLOGY ANALYSIS             78

5.7.1        KEY TECHNOLOGIES     78

5.7.1.1    Artificial intelligence & machine learning        79

5.7.1.2    Internet of things (IoT)       79

5.7.1.3    Mobile applications              79

5.7.1.4    Biosensors and wearable technology 80

5.7.1.5    Gamification technology     80

5.7.1.6    Voice assistants    81

5.7.2        COMPLEMENTARY TECHNOLOGIES       81

5.7.2.1    Smart home automation      81

5.7.2.2    Telemedicine platforms       81

5.7.2.3    Data analysis and visualization tools 82

5.7.2.4    EHR integration   82

5.7.2.5    Cloud computing  83

5.7.3        ADJACENT TECHNOLOGIES       83

5.7.3.1    Fitness trackers     83

5.7.3.2    Respiratory monitoring devices          83

5.7.3.3    Augmented reality (AR) & virtual reality (VR)                84

5.8           REGULATORY ANALYSIS               84

5.8.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             84

5.8.2        REGULATORY SCENARIO             87

5.8.2.1    North America      87

5.8.2.2    Europe   89

5.8.2.3    Asia Pacific            89

5.8.2.4    Middle East & Africa            91

5.8.2.5    Latin America       91

5.9           PRICING ANALYSIS          91

5.9.1        AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)   92

5.9.2        AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)    93

5.10         PORTER’S FIVE FORCES ANALYSIS           94

5.10.1      INTENSITY OF COMPETITIVE RIVALRY 95

5.10.2      BARGAINING POWER OF BUYERS             95

5.10.3      THREAT OF SUBSTITUTES          95

5.10.4      THREAT OF NEW ENTRANTS      95

5.10.5      BARGAINING POWER OF SUPPLIERS       95

5.11         PATENT ANALYSIS          96

5.11.1      PATENT PUBLICATION TRENDS               96

5.11.2      JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE  97

5.11.3      MAJOR PATENTS IN SLEEP SOFTWARE MARKET                 98

5.12         KEY STAKEHOLDERS & BUYING CRITERIA            100

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           100

5.12.2      KEY BUYING CRITERIA  101

5.13         END-USER ANALYSIS      102

5.13.1      UNMET NEEDS 102

5.13.2      END-USER EXPECTATIONS         103

5.14         KEY CONFERENCES & EVENTS, 2025–2026              104

5.15         CASE STUDY ANALYSIS 105

5.15.1      CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE’S SLEEP MEDICINE INSTITUTE      105

5.15.2      CASE STUDY 2: GRANGER MEDICAL CLINIC’S PATH TO EFFICIENT HEALTHCARE OPERATIONS 106

5.16         INVESTMENT & FUNDING SCENARIO     106

5.17         BUSINESS MODEL ANALYSIS      107

5.18         IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET                 107

5.18.1      KEY USE CASES 108

5.18.2      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         109

5.18.2.1  Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep   109

5.18.2.2  Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health       110

5.18.3      IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              111

5.18.3.1  Remote patient monitoring market   111

5.18.3.2  Digital health market           111

5.18.3.3  Telehealth and telemedicine market 112

5.18.3.4  mHealth market    112

5.18.4      USER READINESS AND IMPACT ASSESSMENT     112

5.18.4.1  User readiness       112

5.18.4.1.1                User A: Individual users      112

5.18.4.1.2                User B: Healthcare providers              112

5.18.4.2  Impact assessment                113

5.18.4.2.1                User A: Individual users      113

5.18.4.2.2                User B: Healthcare providers              113

6               SLEEP SOFTWARE MARKET, BY TYPE     115

6.1           INTRODUCTION              116

6.2           INTEGRATED SOFTWARE             116

6.2.1        NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH                 116

6.3           STANDALONE SOFTWARE           117

6.3.1        RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH               117

7               SLEEP SOFTWARE MARKET, BY OFFERING           119

7.1           INTRODUCTION              120

7.2           PLATFORMS       120

7.2.1        GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET     120

7.3           APPLICATIONS 121

7.3.1        MOBILE APPLICATIONS                122

7.3.1.1    Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth             122

7.3.2        DESKTOP APPLICATIONS            123

7.3.2.1    Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth         123

8               SLEEP SOFTWARE MARKET, BY FUNCTION          125

8.1           INTRODUCTION              126

8.2           SLEEP TRACKING             126

8.2.1        RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH              126

8.3           SLEEP IMPROVEMENT  127

8.3.1        INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH                 127

8.4           SLEEP ANALYSIS               128

8.4.1        GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET     128

8.5           SLEEP DISORDER MANAGEMENT             129

8.5.1        INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH  129

9               SLEEP SOFTWARE MARKET, BY INDICATION      131

9.1           INTRODUCTION              132

9.2           INSOMNIA           132

9.2.1        RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH                 132

9.3           SLEEP APNEA    133

9.3.1        GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET               133

9.4           GENERAL SLEEP IMPROVEMENT              134

9.4.1        RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH               134

9.5           OTHER INDICATIONS   136

10            SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL                 137

10.1         INTRODUCTION              138

10.2         ON-PREMISE MODELS   138

10.2.1      NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH       138

10.3         CLOUD-BASED MODELS               139

10.3.1      GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET        139

11            SLEEP SOFTWARE MARKET, BY END USER            141

11.1         INTRODUCTION              142

11.2         INDIVIDUAL USERS         142

11.2.1      GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET                 142

11.3         HEALTHCARE PROVIDERS           143

11.3.1      RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET 143

11.4         OTHER END USERS         144

12            SLEEP SOFTWARE MARKET, BY REGION                145

12.1         INTRODUCTION              146

12.2         NORTH AMERICA             146

12.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 147

12.2.2      US           150

12.2.2.1  Increasing investments due to reduced workplace productivity and decreased quality of life to drive market   150

12.2.3      CANADA               153

12.2.3.1  Government investments and increasing awareness to drive market    153

12.3         EUROPE               156

12.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      156

12.3.2      GERMANY           159

12.3.2.1  Growing need for effective diagnostic and treatment solutions to drive market          159

12.3.3      UK          162

12.3.3.1  Rising interest in sleep management apps to favor market                 162

12.3.4      FRANCE                164

12.3.4.1  Rising awareness and supportive government initiatives to fuel market growth       164

12.3.5      ITALY    167

12.3.5.1  Growing insomnia prevalence in Italy to propel market 167

12.3.6      SPAIN    170

12.3.6.1  Increasing incidence of sleep problems in younger populations to drive demand        170

12.3.7      REST OF EUROPE             172

12.4         ASIA PACIFIC     175

12.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 175

12.4.2      CHINA  179

12.4.2.1  Rising sleep disorder prevalence to drive market            179

12.4.3      INDIA    182

12.4.3.1  Collaborative efforts with other countries to support market growth    182

12.4.4      JAPAN   185

12.4.4.1  Need for digital solutions and government initiatives to drive market    185

12.4.5      REST OF ASIA PACIFIC   187

12.5         LATIN AMERICA                190

12.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 190

12.5.2      BRAZIL 193

12.5.2.1  Rising cases of sleep disorders among older adults to drive market                 193

12.5.3      MEXICO                196

12.5.3.1  Socioeconomic factors and environmental stressors to support market growth       196

12.5.4      REST OF LATIN AMERICA             198

12.6         MIDDLE EAST & AFRICA                201

12.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 201

12.6.2      GCC COUNTRIES              204

12.6.2.1  Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries 204

12.6.3      REST OF MIDDLE EAST & AFRICA             207

13            COMPETITIVE LANDSCAPE         210

13.1         INTRODUCTION              210

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            210

13.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET   210

13.3         REVENUE ANALYSIS, 2019–2023  212

13.4         MARKET SHARE ANALYSIS, 2023                 213

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 216

13.5.1      STARS   216

13.5.2      EMERGING LEADERS     216

13.5.3      PERVASIVE PLAYERS      217

13.5.4      PARTICIPANTS 217

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         218

13.5.5.1  Company footprint               218

13.5.5.2  Region footprint   219

13.5.5.3  Type footprint       220

13.5.5.4  Offering footprint 221

13.5.5.5  Function footprint                222

13.5.5.6  Indication footprint              223

13.5.5.7  Deployment footprint          224

13.5.5.8  End-user footprint                225

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        226

13.6.1      PROGRESSIVE COMPANIES         226

13.6.2      RESPONSIVE COMPANIES            226

13.6.3      DYNAMIC COMPANIES  226

13.6.4      STARTING BLOCKS         226

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 228

13.6.5.1  Detailed list of key startups/SMEs    228

13.6.5.2  Competitive benchmarking of key startups/SMEs          229

13.7         COMPANY VALUATION & FINANCIAL METRICS 229

13.8         BRAND/SOFTWARE COMPARISON           231

13.9         COMPETITIVE SCENARIO             232

13.9.1      PRODUCT LAUNCHES & ENHANCEMENTS           232

13.9.2      DEALS  232

13.9.3      EXPANSIONS     233

13.9.4      OTHER DEVELOPMENTS              234

14            COMPANY PROFILES      235

14.1         KEY PLAYERS     235

14.1.1      CALM    235

14.1.1.1  Business overview 235

14.1.1.2  Solutions offered  236

14.1.1.3  Recent developments           236

14.1.1.3.1                Deals      236

14.1.1.4  MnM view              237

14.1.1.4.1                Right to win           237

14.1.1.4.2                Strategic choices   237

14.1.1.4.3                Weaknesses & competitive threats     237

14.1.2      HEADSPACE INC.              238

14.1.2.1  Business overview 238

14.1.2.2  Solutions offered  238

14.1.2.3  Recent developments           239

14.1.2.3.1                Product launches  239

14.1.2.3.2                Deals      239

14.1.2.3.3                Other developments             240

14.1.2.4  MnM view              240

14.1.2.4.1                Right to win           240

14.1.2.4.2                Strategic choices   240

14.1.2.4.3                Weaknesses & competitive threats     240

14.1.3      RESMED               241

14.1.3.1  Business overview 241

14.1.3.2  Solutions offered  242

14.1.3.3  Recent developments           243

14.1.3.3.1                Product enhancements        243

14.1.3.3.2                Deals      244

14.1.3.3.3                Expansions             245

14.1.3.4  MnM view              245

14.1.3.4.1                Right to win           245

14.1.3.4.2                Strategic choices   245

14.1.3.4.3                Weaknesses & competitive threats     245

14.1.4      KONINKLIJKE PHILIPS N.V.          246

14.1.4.1  Business overview 246

14.1.4.2  Solutions offered  248

14.1.4.3  MnM view              249

14.1.4.3.1                Right to win           249

14.1.4.3.2                Strategic choices   249

14.1.4.3.3                Weaknesses & competitive threats     249

14.1.5      INSPIRE MEDICAL SYSTEMS, INC.             250

14.1.5.1  Business overview 250

14.1.5.2  Solutions offered  251

14.1.5.3  MnM view              251

14.1.5.3.1                Right to win           251

14.1.5.3.2                Strategic choices   251

14.1.5.3.3                Weaknesses & competitive threats     251

14.1.6      CADWELL INDUSTRIES INC.        252

14.1.6.1  Business overview 252

14.1.6.2  Solutions offered  252

14.1.6.3  Recent developments           253

14.1.6.3.1                Deals      253

14.1.7      COMPUMEDICS LIMITED             254

14.1.7.1  Business overview 254

14.1.7.2  Solutions offered  255

14.1.8      NEUROVIRTUAL               256

14.1.8.1  Business overview 256

14.1.8.2  Solutions offered  256

14.1.8.3  Recent developments           257

14.1.8.3.1                Expansions             257

14.1.9      NIHON KOHDEN CORPORATION              258

14.1.9.1  Business overview 258

14.1.9.2  Solutions offered  259

14.1.9.3  Recent developments           260

14.1.9.3.1                Deals      260

14.1.9.3.2                Expansions             260

14.1.10   NOX MEDICAL  261

14.1.10.1                 Business overview 261

14.1.10.2                 Solutions offered  261

14.1.10.3                 Recent developments           262

14.1.10.3.1             Product launches & enhancements    262

14.1.11   NATUS MEDICAL INCORPORATED          263

14.1.11.1                 Business overview 263

14.1.11.2                 Solutions offered  263

14.1.11.3                 Recent developments           264

14.1.11.3.1             Deals      264

14.1.12   RXNT     265

14.1.12.1                 Business overview 265

14.1.12.2                 Solutions offered  265

14.1.12.3                 Recent developments           266

14.1.12.3.1             Product launches  266

14.1.13   CLEVELAND MEDICAL DEVICES INC.      267

14.1.13.1                 Business overview 267

14.1.13.2                 Solutions offered  267

14.1.13.3                 Recent developments           268

14.1.13.3.1             Product enhancements        268

14.1.14   SOMNOMEDICS AG         269

14.1.14.1                 Business overview 269

14.1.14.2                 Solutions offered  269

14.1.14.3                 Recent developments           270

14.1.14.3.1             Deals      270

14.1.15   CIDELEC              271

14.1.15.1                 Business overview 271

14.1.15.2                 Solutions offered  271

14.1.16   SLEEP CYCLE     272

14.1.16.1                 Business overview 272

14.1.16.2                 Solutions offered  273

14.1.16.3                 Recent developments           273

14.1.16.3.1             Product launches  273

14.1.16.3.2             Deals      274

14.1.17   LÖWENSTEIN MEDICAL SE & CO. KG      275

14.1.17.1                 Business overview 275

14.1.17.2                 Solutions offered  275

14.1.18   CAMNTECH LTD.             277

14.1.18.1                 Business overview 277

14.1.18.2                 Solutions offered  277

14.1.18.3                 Recent developments           278

14.1.18.3.1             Product launches  278

14.1.19   FISHER & PAYKEL HEALTHCARE LIMITED            279

14.1.19.1                 Business overview 279

14.1.19.2                 Solutions offered  280

14.1.19.3                 Recent developments           281

14.1.19.3.1             Product launches  281

14.1.19.3.2             Expansions             281

14.1.20   BIOSERENITY    282

14.1.20.1                 Business overview 282

14.1.20.2                 Solutions offered  282

14.1.20.3                 Recent developments           283

14.1.20.3.1             Other developments             283

14.1.21   VYAIRE MEDICAL, INC.  284

14.1.21.1                 Business overview 284

14.1.21.2                 Solutions offered  284

14.2         OTHER PLAYERS              285

14.2.1      HONEYNAPS      285

14.2.2      SLEEPIMAGE     286

14.2.3      SLEEP RESET      287

14.2.4      BIGHEALTH       288

14.2.5      BODYMATTER, INC.        289

14.2.6      NEYBOX DIGITAL LTD. 289

14.2.7      CONSUMER SLEEP SOLUTIONS LLC        290

15            APPENDIX           291

15.1         DISCUSSION GUIDE        291

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                296

15.3         CUSTOMIZATION OPTIONS        298

15.4         RELATED REPORTS         299

15.5         AUTHOR DETAILS           300

LIST OF TABLES

TABLE 1                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                32

TABLE 2                SLEEP SOFTWARE MARKET: FACTOR ANALYSIS                 42

TABLE 3                SLEEP SOFTWARE MARKET: RISK ASSESSMENT ANALYSIS            47

TABLE 4                SLEEP SOFTWARE MARKET: IMPACT ANALYSIS                 58

TABLE 5                ESTIMATED PREVALENCE OF SLEEP APNEA, 2022–2024              60

TABLE 6                INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS

OF UNTREATED SLEEP APNEA  61

TABLE 7                TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024              65

TABLE 8                SLEEP SOFTWARE MARKET: ROLE IN ECOSYSTEM       76

TABLE 9                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 84

TABLE 10              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           85

TABLE 11              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  86

TABLE 12              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  87

TABLE 13              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT

AGENCIES, AND OTHER ORGANIZATIONS           87

TABLE 14              REGULATORY SCENARIO OF NORTH AMERICA                 87

TABLE 15              REGULATORY SCENARIO OF EUROPE    89

TABLE 16              REGULATORY SCENARIO OF ASIA PACIFIC                 89

TABLE 17              REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 91

TABLE 18              REGULATORY SCENARIO OF LATIN AMERICA                 91

TABLE 19              AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)   93

TABLE 20              SLEEP SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS           94

TABLE 21              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE        97

TABLE 22              SLEEP SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS          99

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP

TWO END USERS (%)      101

TABLE 24              KEY BUYING CRITERIA FOR TOP END USERS                 101

TABLE 25              UNMET NEEDS IN SLEEP SOFTWARE MARKET                 102

TABLE 26              END-USER EXPECTATIONS IN SLEEP SOFTWARE MARKET               103

TABLE 27              SLEEP SOFTWARE MARKET: KEY CONFERENCES & EVENTS,

JANUARY 2025- DECEMBER 2026                 104

TABLE 28              SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 116

TABLE 29              SLEEP SOFTWARE MARKET FOR INTEGRATED SOFTWARE, BY REGION,

2022–2030 (USD MILLION)            117

TABLE 30              SLEEP SOFTWARE MARKET FOR STANDALONE SOFTWARE, BY REGION,

2022–2030 (USD MILLION)            118

TABLE 31              SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)       120

TABLE 32              SLEEP SOFTWARE MARKET FOR PLATFORMS, BY REGION,

2022–2030 (USD MILLION)            121

TABLE 33             SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            121

TABLE 34             SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY REGION,

2022–2030 (USD MILLION)            122

TABLE 35              SLEEP SOFTWARE MARKET FOR MOBILE APPLICATIONS, BY REGION,

2022–2030 (USD MILLION)            123

TABLE 36              SLEEP SOFTWARE MARKET FOR DESKTOP APPLICATIONS, BY REGION,

2022–2030 (USD MILLION)            124

TABLE 37              SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            126

TABLE 38              SLEEP SOFTWARE MARKET FOR SLEEP TRACKING, BY REGION,

2022–2030 (USD MILLION)            127

TABLE 39              SLEEP SOFTWARE MARKET FOR SLEEP IMPROVEMENT, BY REGION,

2022–2030 (USD MILLION)            128

TABLE 40              SLEEP SOFTWARE MARKET FOR SLEEP ANALYSIS, BY REGION,

2022–2030 (USD MILLION)            129

TABLE 41              SLEEP SOFTWARE MARKET FOR SLEEP DISORDER MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)            130

TABLE 42              SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)            132

TABLE 43              SLEEP SOFTWARE MARKET FOR INSOMNIA, BY REGION,

2022–2030 (USD MILLION)            133

TABLE 44              SLEEP SOFTWARE MARKET FOR SLEEP APNEA, BY REGION,

2022–2030 (USD MILLION)            134

TABLE 45              SLEEP SOFTWARE MARKET FOR GENERAL SLEEP IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION)                 135

TABLE 46              SLEEP SOFTWARE MARKET FOR OTHER INDICATIONS, BY REGION,

2022–2030 (USD MILLION)            136

TABLE 47              SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)           138

TABLE 48              SLEEP SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION,

2022–2030 (USD MILLION)            139

TABLE 49              SLEEP SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION,

2022–2030 (USD MILLION)            140

TABLE 50              SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)       142

TABLE 51              SLEEP SOFTWARE MARKET FOR INDIVIDUAL USERS, BY REGION,

2022–2030 (USD MILLION)            143

TABLE 52              SLEEP SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION,

2022–2030 (USD MILLION)            144

TABLE 53              SLEEP SOFTWARE MARKET FOR OTHER END USERS, BY REGION,

2022–2030 (USD MILLION)            144

TABLE 54              SLEEP SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)       146

TABLE 55              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            148

TABLE 56              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            148

TABLE 57              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            148

TABLE 58              NORTH AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            149

TABLE 59              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            149

TABLE 60              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            149

TABLE 61              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            150

TABLE 62              NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            150

TABLE 63              US: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)       151

TABLE 64              US: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            151

TABLE 65              US: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            151

TABLE 66              US: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            152

TABLE 67             US: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)            152

TABLE 68              US: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            152

TABLE 69              US: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)            153

TABLE 70              CANADA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            153

TABLE 71              CANADA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     154

TABLE 72              CANADA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            154

TABLE 73              CANADA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   154

TABLE 74              CANADA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                155

TABLE 75              CANADA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            155

TABLE 76              CANADA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                155

TABLE 77              EUROPE: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)     156

TABLE 78              EUROPE: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            157

TABLE 79              EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     157

TABLE 80              EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            157

TABLE 81              EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   158

TABLE 82              EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                158

TABLE 83              EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            158

TABLE 84              EUROPE: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                159

TABLE 85             GERMANY: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            159

TABLE 86              GERMANY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     160

TABLE 87              GERMANY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            160

TABLE 88              GERMANY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   160

TABLE 89              GERMANY: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            161

TABLE 90              GERMANY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            161

TABLE 91              GERMANY: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                161

TABLE 92              UK: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)       162

TABLE 93              UK: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            162

TABLE 94              UK: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            163

TABLE 95              UK: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            163

TABLE 96             UK: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)            163

TABLE 97              UK: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            164

TABLE 98              UK: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)            164

TABLE 99              FRANCE: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            165

TABLE 100            FRANCE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     165

TABLE 101            FRANCE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            165

TABLE 102            FRANCE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   166

TABLE 103            FRANCE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                166

TABLE 104            FRANCE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            166

TABLE 105            FRANCE: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                167

TABLE 106            ITALY: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            167

TABLE 107            ITALY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     168

TABLE 108            ITALY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            168

TABLE 109            ITALY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   168

TABLE 110            ITALY: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                169

TABLE 111            ITALY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            169

TABLE 112            ITALY: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                169

TABLE 113            SPAIN: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            170

TABLE 114            SPAIN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     170

TABLE 115            SPAIN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            171

TABLE 116            SPAIN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   171

TABLE 117            SPAIN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                171

TABLE 118            SPAIN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            172

TABLE 119            SPAIN: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                172

TABLE 120            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            173

TABLE 121            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            173

TABLE 122            REST OF EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)                 173

TABLE 123            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            174

TABLE 124            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            174

TABLE 125            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            174

TABLE 126            REST OF EUROPE: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            175

TABLE 127            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            176

TABLE 128            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)                177

TABLE 129            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            177

TABLE 130            ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            177

TABLE 131            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            178

TABLE 132            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            178

TABLE 133            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            178

TABLE 134            ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            179

TABLE 135            CHINA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            179

TABLE 136            CHINA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     180

TABLE 137            CHINA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            180

TABLE 138            CHINA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   180

TABLE 139            CHINA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                181

TABLE 140            CHINA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            181

TABLE 141            CHINA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                181

TABLE 142            INDIA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            182

TABLE 143            INDIA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     183

TABLE 144            INDIA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            183

TABLE 145            INDIA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   183

TABLE 146            INDIA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                184

TABLE 147            INDIA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            184

TABLE 148            INDIA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                184

TABLE 149            JAPAN: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            185

TABLE 150            JAPAN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     185

TABLE 151            JAPAN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            186

TABLE 152            JAPAN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   186

TABLE 153            JAPAN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                186

TABLE 154            JAPAN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            187

TABLE 155            JAPAN: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                187

TABLE 156            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            188

TABLE 157            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            188

TABLE 158            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)            188

TABLE 159            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            189

TABLE 160            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            189

TABLE 161            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 189

TABLE 162            REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            190

TABLE 163            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            190

TABLE 164            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)                191

TABLE 165            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            191

TABLE 166            LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            191

TABLE 167            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)          192

TABLE 168            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            192

TABLE 169            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            192

TABLE 170            LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            193

TABLE 171            BRAZIL: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            193

TABLE 172            BRAZIL: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     194

TABLE 173            BRAZIL: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            194

TABLE 174            BRAZIL: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   194

TABLE 175            BRAZIL: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                195

TABLE 176            BRAZIL: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            195

TABLE 177            BRAZIL: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                195

TABLE 178            MEXICO: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION)            196

TABLE 179            MEXICO: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     196

TABLE 180            MEXICO: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            197

TABLE 181            MEXICO: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   197

TABLE 182            MEXICO: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                197

TABLE 183            MEXICO: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            198

TABLE 184            MEXICO: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                198

TABLE 185            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)          199

TABLE 186            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            199

TABLE 187            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)            199

TABLE 188            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            200

TABLE 189            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            200

TABLE 190            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 200

TABLE 191            REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            201

TABLE 192            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY REGION,

2022–2030 (USD MILLION)            201

TABLE 193            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            202

TABLE 194            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            202

TABLE 195            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION)            202

TABLE 196            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            203

TABLE 197            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            203

TABLE 198            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 203

TABLE 199            MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            204

TABLE 200            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            204

TABLE 201            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY OFFERING,

2022–2030 (USD MILLION)            205

TABLE 202            GCC COUNTRIES: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE,

2022–2030 (USD MILLION)            205

TABLE 203            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY FUNCTION,

2022–2030 (USD MILLION)            205

TABLE 204            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY INDICATION,

2022–2030 (USD MILLION)            206

TABLE 205            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL,

2022–2030 (USD MILLION)            206

TABLE 206            GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY END USER,

2022–2030 (USD MILLION)            206

TABLE 207            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE,

2022–2030 (USD MILLION)            207

TABLE 208            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)                 207

TABLE 209            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 208

TABLE 210            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)                 208

TABLE 211            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION)                 208

TABLE 212            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            209

TABLE 213            REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION)                 209

TABLE 214            SLEEP SOFTWARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED KEY PLAYERS, JANUARY 2021–JANUARY 2025        210

TABLE 215            SLEEP SOFTWARE MARKET: DEGREE OF COMPETITION 214

TABLE 216            SLEEP SOFTWARE MARKET: REGION FOOTPRINT       219

TABLE 217            SLEEP SOFTWARE MARKET: TYPE FOOTPRINT                 220

TABLE 218            SLEEP SOFTWARE MARKET: OFFERING FOOTPRINT       221

TABLE 219            SLEEP SOFTWARE MARKET: FUNCTION FOOTPRINT       222

TABLE 220            SLEEP SOFTWARE MARKET: INDICATION FOOTPRINT       223

TABLE 221            SLEEP SOFTWARE MARKET: DEPLOYMENT FOOTPRINT       224

TABLE 222            SLEEP SOFTWARE MARKET: END-USER FOOTPRINT       225

TABLE 223            SLEEP SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES    228

TABLE 224            SLEEP SOFTWARE MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES, BY REGION    229

TABLE 225            SLEEP SOFTWARE MARKET: PRODUCT LAUNCHES &

ENHANCEMENTS, JANUARY 2021–JANUARY 2025                232

TABLE 226            SLEEP SOFTWARE MARKET: DEALS, JANUARY 2021–JANUARY 2025         232

TABLE 227            SLEEP SOFTWARE MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025     233

TABLE 228            SLEEP SOFTWARE MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     234

TABLE 229            CALM: COMPANY OVERVIEW     235

TABLE 230            CALM: SOLUTIONS OFFERED    236

TABLE 231            CALM: DEALS, JANUARY 2021–JANUARY 2025                 236

TABLE 232            HEADSPACE INC.: COMPANY OVERVIEW                 238

TABLE 233            HEADSPACE INC.: SOLUTIONS OFFERED                 238

TABLE 234            HEADSPACE INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025     239

TABLE 235            HEADSPACE INC.: DEALS, JANUARY 2021–JANUARY 2025    239

TABLE 236            HEADSPACE INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     240

TABLE 237            RESMED: COMPANY OVERVIEW                241

TABLE 238            RESMED: SOLUTIONS OFFERED                242

TABLE 239            RESMED: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025     243

TABLE 240            RESMED: DEALS, JANUARY 2021–JANUARY 2025                 244

TABLE 241            RESMED: EXPANSIONS, JANUARY 2021–JANUARY 2025        245

TABLE 242            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          246

TABLE 243            KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED             248

TABLE 244            INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW          250

TABLE 245            INSPIRE MEDICAL SYSTEMS, INC.: SOLUTIONS OFFERED             251

TABLE 246            CADWELL INDUSTRIES INC.: COMPANY OVERVIEW          252

TABLE 247            CADWELL INDUSTRIES INC.: SOLUTIONS OFFERED             252

TABLE 248            CADWELL INDUSTRIES INC.: DEALS, JANUARY 2021–JANUARY 2025         253

TABLE 249            COMPUMEDICS LIMITED: COMPANY OVERVIEW          254

TABLE 250            COMPUMEDICS LIMITED: SOLUTIONS OFFERED             255

TABLE 251            NEUROVIRTUAL: COMPANY OVERVIEW                 256

TABLE 252            NEUROVIRTUAL: SOLUTIONS OFFERED                 256

TABLE 253            NEUROVIRTUAL: EXPANSIONS, JANUARY 2021–JANUARY 2025    257

TABLE 254            NIHON KOHDEN CORPORATION: COMPANY OVERVIEW          258

TABLE 255            NIHON KOHDEN CORPORATION: SOLUTIONS OFFERED             259

TABLE 256            NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025     260

TABLE 257            NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025     260

TABLE 258            NOX MEDICAL: COMPANY OVERVIEW   261

TABLE 259            NOX MEDICAL: SOLUTIONS OFFERED   261

TABLE 260            NOX MEDICAL: PRODUCT LAUNCHES & ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     262

TABLE 261            NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW          263

TABLE 262            NATUS MEDICAL INCORPORATED: SOLUTIONS OFFERED             263

TABLE 263            NATUS MEDICAL INCORPORATED: DEALS, JANUARY 2021–JANUARY 2025     264

TABLE 264            RXNT: COMPANY OVERVIEW     265

TABLE 265            RXNT: SOLUTIONS OFFERED     265

TABLE 266            RXNT: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025    266

TABLE 267            CLEVELAND MEDICAL DEVICES INC.: COMPANY OVERVIEW   267

TABLE 268            CLEVELAND MEDICAL DEVICES INC.: SOLUTIONS OFFERED   267

TABLE 269            CLEVELAND MEDICAL DEVICES INC.: PRODUCT ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     268

TABLE 270            SOMNOMEDICS AG: COMPANY OVERVIEW                 269

TABLE 271            SOMNOMEDICS AG: SOLUTIONS OFFERED                 269

TABLE 272            SOMNOMEDICS AG: DEALS, JANUARY 2021–JANUARY 2025    270

TABLE 273            CIDELEC: COMPANY OVERVIEW               271

TABLE 274            CIDELEC: SOLUTIONS OFFERED               271

TABLE 275            SLEEP CYCLE: COMPANY OVERVIEW      272

TABLE 276            SLEEP CYCLE: SOLUTIONS OFFERED     273

TABLE 277            SLEEP CYCLE: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025         273

TABLE 278            SLEEP CYCLE: DEALS, JANUARY 2021–JANUARY 2025        274

TABLE 279            LÖWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW          275

TABLE 280            LÖWENSTEIN MEDICAL SE & CO. KG: SOLUTIONS OFFERED   275

TABLE 281            CAMNTECH LTD.: COMPANY OVERVIEW                 277

TABLE 282            CAMNTECH LTD.: SOLUTIONS OFFERED                 277

TABLE 283            CAMNTECH LTD.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025     278

TABLE 284            FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW   279

TABLE 285            FISHER & PAYKEL HEALTHCARE LIMITED: SOLUTIONS OFFERED   280

TABLE 286            FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES,

JANUARY 2021–JANUARY 2025     281

TABLE 287            FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS,

JANUARY 2021–JANUARY 2025     281

TABLE 288            BIOSERENITY: COMPANY OVERVIEW     282

TABLE 289            BIOSERENITY: SOLUTIONS OFFERED     282

TABLE 290            BIOSERENITY: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     283

TABLE 291            VYAIRE MEDICAL, INC.: COMPANY OVERVIEW                 284

TABLE 292            VYAIRE MEDICAL, INC.: SOLUTIONS OFFERED                 284

TABLE 293            HONEYNAPS: COMPANY OVERVIEW       285

TABLE 294            SLEEPIMAGE: COMPANY OVERVIEW      286

TABLE 295            SLEEP RESET: COMPANY OVERVIEW      287

TABLE 296            BIGHEALTH: COMPANY OVERVIEW        288

TABLE 297            BODYMATTER, INC.: COMPANY OVERVIEW                 289

TABLE 298            NEYBOX DIGITAL LTD.: COMPANY OVERVIEW                 289

TABLE 299            CONSUMER SLEEP SOLUTIONS LLC: COMPANY OVERVIEW          290

LIST OF FIGURES

FIGURE 1              MARKETS & REGIONS COVERED               30

FIGURE 2              RESEARCH DESIGN         34

FIGURE 3              PRIMARY SOURCES         37

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                38

FIGURE 5              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           39

FIGURE 6              SUPPLY-SIDE MARKET ESTIMATION      40

FIGURE 7              CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)          43

FIGURE 8              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 44

FIGURE 9              TOP-DOWN APPROACH                44

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 45

FIGURE 11            SLEEP SOFTWARE MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)       49

FIGURE 12            SLEEP SOFTWARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION)                49

FIGURE 13            SLEEP SOFTWARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)                50

FIGURE 14            SLEEP SOFTWARE MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)      50

FIGURE 15            SLEEP SOFTWARE MARKET, BY DEPLOYMENT, 2024 VS. 2030 (USD MILLION)      51

FIGURE 16            SLEEP SOFTWARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)                52

FIGURE 17            SLEEP SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT          53

FIGURE 18            AWARENESS REGARDING SLEEP-RELATED DISORDERS AND HIGH RETURNS ON INVESTMENT FOR SLEEP SOFTWARE SOLUTIONS TO DRIVE MARKET GROWTH   54

FIGURE 19            INDIVIDUAL USERS IN NORTH AMERICA ACCOUNTED FOR

LARGEST MARKET SHARE IN 2023             55

FIGURE 20            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       56

FIGURE 21            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED ECONOMIES DURING FORECAST PERIOD         56

FIGURE 22            SLEEP SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         57

FIGURE 23            HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024           63

FIGURE 24            MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR IN US, 2009–2024    64

FIGURE 25            INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023   64

FIGURE 26            WORLD POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2015–2023    68

FIGURE 27            REGIONAL POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2023        69

FIGURE 28            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN

SLEEP SOFTWARE MARKET         72

FIGURE 29            SLEEP SOFTWARE MARKET: ECOSYSTEM ANALYSIS            75

FIGURE 30            SLEEP SOFTWARE MARKET: SUPPLY CHAIN ANALYSIS            77

FIGURE 31            AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)           92

FIGURE 32            SLEEP SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS           94

FIGURE 33            PATENT PUBLICATION TRENDS IN SLEEP SOFTWARE MARKET, 2015–2024 96

FIGURE 34            JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE PATENTS (JANUARY 2015–DECEMBER 2024)              97

FIGURE 35            MAJOR PATENTS IN SLEEP SOFTWARE MARKET

(JANUARY 2015–DECEMBER 2024)              98

FIGURE 36            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS            100

FIGURE 37            KEY BUYING CRITERIA FOR TOP END USERS                 101

FIGURE 38            RECENT FUNDING OF PLAYERS IN SLEEP SOFTWARE MARKET       106

FIGURE 39            MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING SLEEP SOFTWARE ACROSS INDUSTRIES    108

FIGURE 40            NORTH AMERICA: SLEEP SOFTWARE MARKET SNAPSHOT          147

FIGURE 41            ASIA PACIFIC: SLEEP SOFTWARE MARKET SNAPSHOT          176

FIGURE 42            REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET,

2019–2023 (USD MILLION)            213

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET (2023)            214

FIGURE 44            SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         217

FIGURE 45            SLEEP SOFTWARE MARKET: COMPANY FOOTPRINT       218

FIGURE 46            SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023                227

FIGURE 47            EV/EBITDA OF KEY SLEEP SOFTWARE VENDORS (2025)    229

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF SLEEP SOFTWARE VENDORS (2024)    230

FIGURE 49            SLEEP SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS            231

FIGURE 50            RESMED: COMPANY SNAPSHOT                242

FIGURE 51            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT          247

FIGURE 52            INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT          250

FIGURE 53            COMPUMEDICS LIMITED: COMPANY SNAPSHOT          254

FIGURE 54            NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT          259

FIGURE 55            SLEEP CYCLE: COMPANY SNAPSHOT     272

FIGURE 56            FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT   280

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧